|
Lipids and Lipid Disorders
Citations 181-190 of 193 total displayed.
|
Past content
(since Jan 1998):
|
- Original Investigations
Prediction of Myocardial Infarction in Dyslipidemic Men by Elevated Levels of Immunoglobulin Classes A, E, and G, but Not M
- Petri T. Kovanen; Matti Mänttäri; Timo Palosuo; Vesa Manninen; Kimmo Aho
Arch Intern Med 1998; 158: 1434-1439.
[Abstract]
[Full text]
- Original Investigations
Fluctuations in Blood Lipid Levels During Furosemide Therapy: A Randomized, Double-blind, Placebo-Controlled Crossover Study
- Norman Campbell; Rollin Brant; Helga Stalts; James Stone; Houman Mahallati
Arch Intern Med 1998; 158: 1461-1463.
[Abstract]
[Full text]
- Original Investigations
Mediterranean Dietary Pattern in a Randomized Trial: Prolonged Survival and Possible Reduced Cancer Rate
- Michel de Lorgeril; Patricia Salen; Jean-Louis Martin; Isabelle Monjaud; Philippe Boucher; Nicolle Mamelle
Arch Intern Med 1998; 158: 1181-1187.
[Abstract]
[Full text]
[PDF]
- Original Investigations
Garlic Powder and Plasma Lipids and Lipoproteins: A Multicenter, Randomized, Placebo-Controlled Trial
- Jonathan L. Isaacsohn; Marvin Moser; Evan A. Stein; Karen Dudley; Janice A. Davey; Ellen Liskov; Henry R. Black
Arch Intern Med 1998; 158: 1189-1194.
[Abstract]
[Full text]
[PDF]
- Corrections
Error in Figure Legends
-
Arch Intern Med 1998; 158: 1228.
[Full text]
[PDF]
- Original Investigations
Primary Care Practice Adherence to National Cholesterol Education Program Guidelines for Patients With Coronary Heart Disease
- Patrick McBride; Helmut G. Schrott; Mary Beth Plane; Gail Underbakke; Roger L. Brown
Arch Intern Med 1998; 158: 1238-1244.
[Abstract]
[Full text]
[PDF]
- Original Investigations
Effective Lipid Modification by Partial Ileal Bypass Reduced Long-term Coronary Heart Disease Mortality and Morbidity: Five-Year Posttrial Follow-up Report From the POSCH
- Henry Buchwald; Richard L. Varco; James R. Boen; Stanley E. Williams; Betty J. Hansen; Christian T. Campos; Gilbert S. Campbell; Malcolm B. Pearce; Albert E. Yellin; W. Allan Edmiston; Robert D. Smink Jr; Henry S. Sawin Jr; for the POSCH Group
Arch Intern Med 1998; 158: 1253-1261.
[Abstract]
[Full text]
[PDF]
- Original Investigations
Main Risk Factors for Nephropathy in Type 2 Diabetes Mellitus Are Plasma Cholesterol Levels, Mean Blood Pressure, and Hyperglycemia
- Mordchai Ravid; David Brosh; Dorit Ravid-Safran; Zohar Levy; Rita Rachmani
Arch Intern Med 1998; 158: 998-1004.
[Abstract]
[Full text]
[PDF]
- Original Investigations
Changes in Plasma Lipids and Lipoproteins in Humans During a 2-Year Period of Dietary Restriction in Biosphere 2
- Roy B. Verdery; Roy L. Walford
Arch Intern Med 1998; 158: 900-906.
[Abstract]
[Full text]
[PDF]
- Review Articles
An Overview of the Clinical Safety Profile of Atorvastatin (Lipitor), a New HMG-CoA Reductase Inhibitor
- Donald M. Black; Rebecca G. Bakker-Arkema; James W. Nawrocki
Arch Intern Med 1998; 158: 577-584.
[Abstract]
[Full text]
[PDF]
|
|
